Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Mónica Guevara & Vicente Arroyo. (2011) Hepatorenal syndrome. Expert Opinion on Pharmacotherapy 12:9, pages 1405-1417.
Read now
Read now
Søren Møller, Flemming Bendtsen & Jens H. Henriksen. (2005) Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scandinavian Journal of Gastroenterology 40:5, pages 491-500.
Read now
Read now
S. Schytte, M. Hansen, S. Møller, P. Junker, J. H. Henriksen, J. Hillingsø, B. Teisner. (1999) Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Scandinavian Journal of Clinical and Laboratory Investigation 59:8, pages 627-633.
Read now
Read now
N. Sato, S. Kawano, T. Matsumura, H. Meren, H. Yoshmara, T. Hijioka, H. Eguchi, H. Fukui & T. Kamada. (1989) Characterization of Hepatic Hemodynamics in Cirrhotics and Non-Cirrhotics Effect of Glucagon Infusion. Scandinavian Journal of Gastroenterology 24:2, pages 223-230.
Read now
Read now
J. H. Henriksen, H. Ring-larsen & N. J. Christensen. (1985) Circulating Noradrenaline and Central Haemodynamics in Patients with Cirrhosis. Scandinavian Journal of Gastroenterology 20:10, pages 1185-1190.
Read now
Read now
J. H. Henriksen. (1983) The ‘Overflow’ Theory of Ascites Formation: A Fading Concept?. Scandinavian Journal of Gastroenterology 18:7, pages 833-837.
Read now
Read now
H. Ring-Larsen, K. Tønnesen, M. Holm-Bentzen & L. A. Christiansen. (1979) Renal and Cerebral Blood Flow in Experimental Liver Failure in the Pig. Scandinavian Journal of Gastroenterology 14:1, pages 91-96.
Read now
Read now
Articles from other publishers (57)
Luyan Zheng, Yining Lu, Jie Wu & Min Zheng. (2023) Development and validation of a prognostic nomogram model for ICU patients with alcohol-associated cirrhosis. Digestive and Liver Disease 55:4, pages 498-504.
Crossref
Crossref
Nora V. Bergasa. 2022. Clinical Cases in Hepatology. Clinical Cases in Hepatology
443
486
.
Irtiza Hasan, Tasnuva Rashid, Razvan M Chirila, Peter Ghali & Hani M. Wadei. (2021) Hepatorenal syndrome: pathophysiology and evidence-based management update. Romanian Journal of Internal Medicine 59:3, pages 227-261.
Crossref
Crossref
Juan Carlos Q. Velez, George Therapondos & Luis A. Juncos. (2019) Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nature Reviews Nephrology 16:3, pages 137-155.
Crossref
Crossref
Ahmed Abdel-Razik, Nasser Mousa, Mostafa Abdelsalam, Ahmed Abdelwahab, Mona Tawfik, Ahmed M. Tawfik, Ahmad S. Hasan, Rania Elhelaly, Niveen El-Wakeel & Waleed Eldars. (2020) Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome. Frontiers in Pharmacology 11.
Crossref
Crossref
Yeon Seok Seo, Soo Young Park, Moon Young Kim, Sang Gyune Kim, Jun Yong Park, Hyung Joon Yim, Byoung Kuk Jang, Seung Ha Park, Ji Hoon Kim, Ki Tae Suk, Jin Dong Kim, Tae Yeob Kim, Eun Young Cho, Jun Sung Lee, Soung Won Jung, Jae Young Jang, Hyonggin An, Won Young Tak, Soon Koo Baik, Jae Seok Hwang, Young Seok Kim, Joo Hyun Sohn & Soon Ho Um. (2018) Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites. Journal of Gastroenterology and Hepatology 33:4, pages 910-917.
Crossref
Crossref
Victoria K. Snowdon, Neil J. Lachlan, Anna M. Hoy, Patrick W. F. Hadoke, Scott I. Semple, Dilip Patel, Will Mungall, Timothy J. Kendall, Adrian Thomson, Ross J. Lennen, Maurits A. Jansen, Carmel M. Moran, Antonella Pellicoro, Prakash Ramachandran, Isaac Shaw, Rebecca L. Aucott, Thomas Severin, Rajnish Saini, Judy Pak, Denise Yates, Neelesh Dongre, Jeremy S. Duffield, David J. Webb, John P. Iredale, Peter C. Hayes & Jonathan A. Fallowfield. (2017) Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial. PLOS Medicine 14:2, pages e1002248.
Crossref
Crossref
Danielle Adebayo, Vincenzo Morabito, Andrew Davenport & Rajiv Jalan. (2015) Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney International 87:3, pages 509-515.
Crossref
Crossref
Jens H. Henriksen & Søren Møller. (2013) Ascites. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 5:1, pages 1-116.
Crossref
Crossref
Juan Carlos Q. Velez & Paul J. Nietert. (2011) Therapeutic Response to Vasoconstrictors in Hepatorenal Syndrome Parallels Increase in Mean Arterial Pressure: A Pooled Analysis of Clinical Trials. American Journal of Kidney Diseases 58:6, pages 928-938.
Crossref
Crossref
Vicente Arroyo & Javier Fernández. (2011) Management of hepatorenal syndrome in patients with cirrhosis. Nature Reviews Nephrology 7:9, pages 517-526.
Crossref
Crossref
Marco Di Pascoli, Francesca Zampieri, Santina Quarta, David Sacerdoti, Carlo Merkel, Angelo Gatta & Massimo Bolognesi. (2011) Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats. Journal of Hepatology 54:2, pages 258-264.
Crossref
Crossref
Yoshihito Kato, Yasumi Katsuta, Xue-Jun Zhang, Masaru Ohsuga, Toshio Akimoto, Akiko Miyamoto, Hirokazu Komeichi, Shuji Shimizu & Kyoichi Mizuno. (2011) Inhibition of Nitric Oxide Synthase in Hyperdynamic Circulation of Rats with Early or Late Cirrhosis Secondary to Common Bile Duct Ligation. Journal of Nippon Medical School 78:3, pages 146-155.
Crossref
Crossref
Jens H. Henriksen. 2011. Chronic Liver Failure. Chronic Liver Failure
239
267
.
Søren Møller, Jens H. Henriksen & Flemming Bendtsen. (2008) Pathogenetic background for treatment of ascites and hepatorenal syndrome. Hepatology International 2:4, pages 416-428.
Crossref
Crossref
Guadalupe Garcia-Tsao, Chirag R. Parikh & Antonella Viola. (2008) Acute kidney injury in cirrhosis. Hepatology 48:6, pages 2064-2077.
Crossref
Crossref
Vanessa P. Stadlbauer, Gavin A.K. Wright, Murad Banaji, Ashis Mukhopadhya, Rajeshwar Mookerjee, Kevin Moore & Rajiv Jalan. (2008) Relationship Between Activation of the Sympathetic Nervous System and Renal Blood Flow Autoregulation in Cirrhosis. Gastroenterology 134:1, pages 111-119.e2.
Crossref
Crossref
Marie-Noëlle Pépin & Pere Ginès. 2008. Therapy in Nephrology & Hypertension. Therapy in Nephrology & Hypertension
47
57
.
Florence Wong, Kevin Moore, Jasper Dingemanse & Rajiv Jalan. (2007) Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome. Hepatology 47:1, pages 160-168.
Crossref
Crossref
Pere Gins & Mnica Guevara. 2007. Textbook of Hepatology. Textbook of Hepatology
711
719
.
Hani M. Wadei, Martin L. Mai, Nasimul Ahsan & Thomas A. Gonwa. (2006) Hepatorenal Syndrome: Pathophysiology and Management. Clinical Journal of the American Society of Nephrology 1:5, pages 1066-1079.
Crossref
Crossref
Mónica Guevara, Rolando Ortega, Pere Ginès & Juan Rodés. 2005. Ascites and Renal Dysfunction in Liver Disease. Ascites and Renal Dysfunction in Liver Disease
327
340
.
Dierk Werner, Peter Trägner, Andrea Wawer, Heiner Porst, Werner G. Daniel & Peter Gross. (2005) Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis. Nephrology Dialysis Transplantation 20:5, pages 920-926.
Crossref
Crossref
Giovanni Sansoè, Stefano Silvano, Giulio Mengozzi, Antonina Smedile, Giovanni Touscoz, Floriano Rosina & Mario Rizzetto. (2005) Loss of Tubuloglomerular Feedback in Decompensated Liver Cirrhosis: Physiopathological Implications. Digestive Diseases and Sciences 50:5, pages 955-963.
Crossref
Crossref
Kevin Moore. 2005. Portal Hypertension. Portal Hypertension
343
362
.
P. Ginès, A. Torre, C. Terra & M. Guevara. (2004) Pharmacological treatment of hepatorenal syndrome. Alimentary Pharmacology & Therapeutics 20, pages 57-62.
Crossref
Crossref
Giovanni Sansoé, Stefano Silvano, Giulio Mengozzi, Luca Todros, Antonina Smedile, Giovanni Touscoz, Floriano Rosina & Mario Rizzetto. (2004) Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. Journal of Hepatology 40:3, pages 417-423.
Crossref
Crossref
Sema AydoGdu, Ipek Akil, Talha Akil, Caner Kabasakal, Refik Killi, Sevgi Mir & RaSit YaGci. (2004) Renal resistive indexes and some renal functions in liver cirrhotic children. Pediatrics International 46:1, pages 67-71.
Crossref
Crossref
Pere Ginès, Mónica Guevara, Vicente Arroyo & Juan Rodés. (2003) Hepatorenal syndrome. The Lancet 362:9398, pages 1819-1827.
Crossref
Crossref
Laurence Blendis & Florence Wong. (2001) The hyperdynamic circulation in cirrhosis. Pharmacology & Therapeutics 89:3, pages 221-231.
Crossref
Crossref
Paloma Rendón Unceta, Manuel Alberto Macías Rodríguez, Pablo Guillén Mariscal, María Tejada Cabrera, M. Carmen Martínez Sierra & Leopoldo Martín Herrera. (2001) Ecografía Doppler renal y su relación con la función renal en pacientes con cirrosis hepática. Medicina Clínica 116:15, pages 561-564.
Crossref
Crossref
Ottesen, Flyvbjerg, Møller & Bendtsen. (2001) The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients. Alimentary Pharmacology & Therapeutics 12:7, pages 657-665.
Crossref
Crossref
David Sacerdoti, Massimo Bolognesi, Carlo Merkel, Paolo Angeli & Angelo Gatta. (1993) Renal vasoconstriction in cirrhosis evaluated by duplex doppler ultrasonography. Hepatology 17:2, pages 219-224.
Crossref
Crossref
Kevin Moore, Julia Wendon, Marshall Frazer, John Karani, Roger Williams & Kamal Badr. (1992) Plasma Endothelin Immunoreactivity in Liver Disease and the Hepatorenal Syndrome. New England Journal of Medicine 327:25, pages 1774-1778.
Crossref
Crossref
S P Wilkinson, K P Moore & V Arroyo. (1991) Pathogenesis of ascites and hepatorenal syndrome.. Gut 32:Suppl, pages S12-S17.
Crossref
Crossref
C.J. Eagle & L. Strunin. (1990) Drug metabolism in liver disease. Current Anaesthesia & Critical Care 1:4, pages 204-212.
Crossref
Crossref
Kevin P. Moore, Graham W. Taylor, Nicola H. Maltby, Derek Siegers, Richard W. Fuller, Colin T. Dollery & Roger Williams. (1990) Increased production of cysteinyl leukotrienes in hepatorenal syndrome. Journal of Hepatology 11:2, pages 263-271.
Crossref
Crossref
Kirsten D. Bentsen, Jens H. Henriksen, Flemming Bendtsen, Kim Hørslev-Petersen & Ib Lorenzen. (1990) Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology 11:6, pages 957-963.
Crossref
Crossref
K. Moore, V. Parsons, P. Ward & R. Williams. 1990. Acute Renal Failure in the Intensive Therapy Unit. Acute Renal Failure in the Intensive Therapy Unit
143
155
.
J H HenriksenN J ChristensenH Ring-Larsen. (1989) Continuous infusion of tracer norepinephrine may miscalculate unidirectional nerve uptake of norepinephrine in humans.. Circulation Research 65:2, pages 388-395.
Crossref
Crossref
L. M. Blendis. 1989. Modern Concepts in Gastroenterology Volume 2. Modern Concepts in Gastroenterology Volume 2
69
87
.
J. H. Henriksen, H. Ring‐Larsen & N. J. Christensen. (2008) Kidney, lower limb and whole‐body uptake and release of catecholamines in alcoholic liver disease. Clinical Physiology 8:3, pages 203-213.
Crossref
Crossref
Jens H. Henriksen, Kirsten D. Bentsen & Torvard C. Laurent. (1988) Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. Journal of Hepatology 6:2, pages 158-166.
Crossref
Crossref
H. Wernze. 1987. Funktion und Funktionsdiagnostik der Leber. Funktion und Funktionsdiagnostik der Leber
183
190
.
J. H. HENRIKSEN, P. STAUN‐OLSEN, N. BORG MOGENSEN & J. FAHRENKRUG. (2008) Circulating endogenous vasoactive intestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis. European Journal of Clinical Investigation 16:3, pages 211-216.
Crossref
Crossref
Jens H. Henriksen, Helmer Ring-Larsen & Niels Juel Christensen. (1985) Sympathetic nervous activity in cirrhosis. Journal of Hepatology 1:1, pages 55-65.
Crossref
Crossref
J H Henriksen, H Ring-Larsen, I L Kanstrup & N J Christensen. (1984) Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.. Gut 25:10, pages 1034-1043.
Crossref
Crossref
Helmer Ring‐Larsen. (2008) Hepatic nephropathy, related to haemodynamics. Liver 3:5, pages 265-289.
Crossref
Crossref
W. Burghardt, H. Wernze, W. Tittor, L. Knebel, W. Tschöpe, J. Potempa, E. Ritz, K. B. G. Sprenger, V. Krivan, H. Geiger, H. E. Franz, K. W. Rumpf, H. Kaiser, H.-H. Goebel, H. A. Wagner, B. Ullmann, F. Scheler, D. Niese, P. Dreßen, E. Hiester, K. Gilsdorf, R. E. Schmidt, H. J. Dengler, P. Schauder, K. Schröder, L. Herbertz, D. Matthaei, H. V. Henning, U. Langenbeck, H. Heidemann, W. Kirch, J. Gerkens, R. Branch, P. Grützmacher, W. Siede, B. Peschke, J. Riepenhausen, M. Buck, W. Schoeppe, J. Passlick, A. Frank, M. Berger, B. Grabensee, W. Cremer, N. Graben, K. P. Krieger, W. H. Boesken, G. Hörth, D. Maas, P. Schollmeyer, E. Heidbreder, J. Dorer, W. H. Hörl, A. Heidland, H. Kopsa, W. Czech, P. Schmidt, J. Zazgornik, P. Balcke, E. Minar, E. Deutsch, W. Quintes, F.-P. Kuhn, A. Geisler-Quintes, M. Weber, E. Keidel, H. Köhler, U. Reinhard, A. Mikulla, A. Schwarz, S. Seyfert, F. Keller, M. Molzahn, H.-H. Neumayer, M. Gregor, K. Wagner, H. Pickartz, R. Sörensen, E.-O. Riecken, D. Tscholakoff, L. Marosi, H. Czembirek, H. Mann, N. Maurin, R. Ziegan, S. Stiller, W. Arnold, G. Renschin, H. H. Dormeyer, K.-H. Meyer zum Büschenfelde, T. Königshausen, D. Hein, J. Wanzlick, H. B. Steinhauer, B. Günter, H. U. Klehr, H. H. von Burgsdorff, H. J. Kaschell, H. G. Münch, L. A. Castro, G. Hillebrand, B. Schneider, W. Land, H. J. Gurland, R. E. Scharf, W. Grzibiela, B. Hartmann, E. Schnurr, W. Schneider, H. Trengut, U. Nyman, J. Hildell, B. Husberg, E. Schulz, R. H. Dennin, K. Sack, J. Herhahn & J. Hoyer. 1983. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin
901
982
.
Helmer Ring-Larsen, Birger Hesse, Jens H. Henriksen & Niels J. Christensen. (2007) Sympathetic Nervous Activity and Renal and Systemic Hemodynamics in Cirrhosis: Plasma Norepinephrine Concentration, Hepatic Extraction, and Renal Release. Hepatology 2:3, pages 304S-310S.
Crossref
Crossref
Helmer Ring-Larsen, Jens H. Henriksen, Birger Hesse & Niels Juel Christensen. (1981) THE ROLE OF INCREASED SYMPATHETIC NERVOUS ACTIVITY FOR THE REDUCED RENAL BLOOD FLOW IN PATIENTS WITH CIRRHOSIS. Clinical Physiology 1:s1, pages 71-75.
Crossref
Crossref
S P Wilkinson. (1981) The kidney and liver diseases.. Journal of Clinical Pathology 34:11, pages 1241-1244.
Crossref
Crossref
L. SELLARS, A. C. SHORE, R. WILKINSON, O. F. W. JAMES & V. ROBSON. (1981) Sodium status and the renin-angiotensin-aldosterone system in compensated liver disease. European Journal of Clinical Investigation 11:4, pages 299-304.
Crossref
Crossref
H Ring-Larsen & U Palazzo. (1981) Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.. Gut 22:7, pages 585-591.
Crossref
Crossref
Jens H. Henriksen, Niels Juel Christensen & Helmer Ring‐Larsen. (2008) Noradrenaline and adrenaline concentrations in various vascular beds in patients with cirrhosis Relation to haemodynamics.. Clinical Physiology 1:3, pages 293-304.
Crossref
Crossref
V. ARROYO, J. BOSCH, M. MAURI, F. RIBERA, F. NAVARRO‐LÓPEZ & J. RODÉS. (2008) Effect of angiotensin‐ll blockade on systemic and hepatic haemodynamics and on the renin‐angiotensin‐aldosterone system in cirrhosis with ascites. European Journal of Clinical Investigation 11:3, pages 221-229.
Crossref
Crossref
Jens H. Henriksen & Niels A. Lassen. (2008) Decreased renal function in cirrhosis–an adaptive response?. Clinical Physiology 1:2, pages 131-138.
Crossref
Crossref